This most current twist during the Lykos Therapeutics saga threatens a major overhaul of the organization’s approach and route, with Musk ally and billionaire Trader Antonio Gracias showing up to need to get the company back again towards its nonprofit drug development roots and a more Doblinite philosophy.“This could have took place up to now,